https://www.selleckchem.com/products/3-typ.html
pFCSRT + IR scores may be more sensitive to early pathological changes than either the CDR-SB or the MMSE. pFCSRT + IR scores may be more sensitive to early pathological changes than either the CDR-SB or the MMSE. The ultimate validation of a clinical marker for Alzheimer's disease (AD) is its association with AD neuropathology. To examine how well the Stages of Objective Memory Impairment (SOMI) system predicts intermediate/high AD neuropathologic change and extent of neurofibrillary tangle (NFT) pathology defined by Braak stage, in comp
Curtir
Comentario
Compartilhar
